FDA Inspection 1060687 — Rechon Life Science AB

Rechon Life Science AB — FEI 3002806978

The FDA completed an inspection of Rechon Life Science AB on June 29, 2018 in Limhamn. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 29, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Limhamn (Sweden)